| Name | Title | Contact Details |
|---|
RevGen GENIUS stands as a premier source for aiding businesses in crafting a robust and efficient go-to-market (GTM) strategy. With our expert guidance, clients can drive revenue growth with confidence.
In 1990, Nitro Snowboards was founded by Thomas Delago and Sepp Ardelt in Seattle, Washington. Over the last 25 years Nitro has helped grow the sport of snowboarding through its groundbreaking product development, marketing, movies, grass roots events, and global team of world class snowboarders. Today Nitro has grown its product to offer all the essentials needed for having a good time snowboarding and traveling. Nitro´s headquarters are divided all over the world from the Mountains of Oberammergau, to the worlds best snow in Salt Lake City, UT, to the creative beaches of California, all the way up to the Northwest snowboarding destination of Vancouver, British Colombia. For more information visit us at http://www.nitrosnowboards.com or @NITROUSA on Instagram
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
AESSEAL designs and manufactures sealing solutions for a sustainable future. We work with global customers in every major industrial sector to improve the reliability, safety and environmental performance of industrial equipment. An industry pioneer, we were founded in 1979 and operate from 231 locations in 104 countries, with a total focus on achieving exceptional quality: in terms of products, technical innovation, customer service, after sales support and care for the environment.
Ondaro, formerly known as Cask NX, is a business and technology consulting firm based in the USA. Founded in 2004, the company has a team of approximately 51-200 employees. Ondaro focuses on helping organizations enhance their operations and achieve growth through technology-driven solutions. The firm specializes in a variety of services centered around the ServiceNow platform. These include business and technology consulting to optimize operations, the development of ServiceNow-based applications that improve user experiences, and the integration of Generative AI to boost productivity. Ondaro also offers HR service delivery solutions with their product "Cask HR Essentials," which automates HR processes, and provides asset data migration services to facilitate efficient transitions to ServiceNow. Ondaro serves a diverse clientele, including state agencies and global manufacturers, helping them modernize operations and improve efficiency through strategic technology initiatives. The company positions itself as a partner for organizations looking to leverage advanced technology solutions for business transformation.